115 filings
Page 4 of 6
8-K
hfazv82g
6 May 22
Termination of a Material Definitive Agreement
4:06pm
DEFA14A
v77m98
28 Apr 22
Additional proxy soliciting materials
5:05pm
8-K
op67f4p1c vs
31 Mar 22
Silverback Therapeutics Updates Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results
12:00am
8-K
brfcxzd7t40s88ai
17 Mar 22
Departure of Directors or Certain Officers
4:05pm
EFFECT
71l4rwrxi4dzzm2f0o
14 Jan 22
Notice of effectiveness
12:15am
CORRESP
f9oo7
11 Jan 22
Correspondence with SEC
12:00am
UPLOAD
8sz45w tq
10 Jan 22
Letter from SEC
12:00am
S-8
yp2zrtlit
3 Jan 22
Registration of securities for employees
4:29pm
S-3
ph29ge0p
3 Jan 22
Shelf registration
4:26pm
8-K
ydbs619xtp4q146
10 Nov 21
Silverback Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
4:20pm
8-K
nzfnvz78cpkhzx1u4v
16 Sep 21
Regulation FD Disclosure
7:37am
8-K
531 wev91zs
13 Sep 21
Regulation FD Disclosure
8:06am
8-K
uj5wvi3kp
12 Aug 21
Silverback Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
4:16pm
8-K
n9hysyaovxz6ht2egb5t
2 Jul 21
Entry into a Material Definitive Agreement
4:06pm
8-K
s7lqyouatf d8de5f
9 Jun 21
Submission of Matters to a Vote of Security Holders
4:10pm
10-Q
p8i 7zkce
13 May 21
Quarterly report
4:21pm